No Detail Found!

Differential binding of repurposed HIV protease inhibitors for SARS-COV-2

Author(s)
Hamdullah Khadim Sheikh Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi,,Pakistan; Molecular Sciences and Research Pvt. Ltd.,,Pakistan
Tanzila Arshad Department of Applied Chemistry, University of Karachi,,Pakistan; Molecular Sciences and Research Pvt. Ltd.,,Pakistan
Zainab Sher Mohammad Molecular Sciences and Research Pvt. Ltd. Pakistan; Physical therapy, Health Sciences, Riphah International University, Islamabad, Pakistan.
Iqra Arshad Research Centre for Modelling & Simulation, National University of Science & Technology,Islamabad, Pakistan
Mohtasheemul Hassan Department of Pharmacognosy, Faculty of Pharmacy, University of Karachi,,Pakistan
Abstract
Herein, molecular structure of SARS-CoV-2 main protease (Mpro) was used for docking or binding energy analysis with medicinally known anti-HIV protease inhibitor drug molecules at changing pH (4-8). Variance analysis performed on binding energies between pH 4-8 confirmed that the binding energy and mode of interaction of some ligands were variable with pH. Among the selected repurposed protease inhibitors, indinavir and saquinavir showed to have the highest differential binding energy with the changing pH. Using the variance analysis, we also proposed novel structural derivative of saquinavir as a pH sensitive specific protease inhibitor with higher pH related selectivity. Hence, the most pH selective protease inhibitors for treatment of SARS-CoV-2 were identified.
Publication Details
Page(s) 5-9
DOI DOI not available
Published Journal: International Journal of Biology and Biotechnology, Volume: 18, Issue: 1, Year: 2021

Request the full text from PASTIC

Keywords
HIV, docking, SARS-CoV-2, Protease inhibitors
0

Citations

0

Downloads

32

Views